Targeting Notch4 in Cancer: Molecular Mechanisms and Therapeutic Perspectives

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Notch signaling pathway dysregulation is implicated in numerous cancers.
• Abnormal Notch4 receptor expression influences key tumor-cell behaviors like stemness, epithelial-mesenchymal transition, and angiogenesis.
• Notch4 activation contributes to radio/chemoresistance in cancer cells.

Purpose of the Study:

• To review the molecular mechanisms by which Notch4 signaling promotes cancer progression.
• To discuss current and potential therapeutic strategies targeting Notch4 in cancer treatment.

Main Methods:

• Literature review of studies on Notch4 signaling in cancer.
• Analysis of molecular mechanisms linking Notch4 to cancer hallmarks.
• Synthesis of information on Notch4-targeting therapeutic approaches.

Main Results:

• Notch4 dysregulation is a significant factor in cancer development and progression.
• Notch4 influences cancer stemness, epithelial-mesenchymal transition, angiogenesis, and therapeutic resistance.
• Various strategies are being explored to inhibit oncogenic Notch4 signaling.

Conclusions:

• Understanding Notch4's role is crucial for developing effective cancer therapies.
• Targeting Notch4 signaling presents a promising avenue for future cancer treatment strategies.
• Further research into Notch4-targeting therapeutics is warranted.